Course opens: 
10/21/2020

Hazardous Drug Decontamination – Understanding its Purpose and Validating Best Practices (PFM On-demand)

Brought to you in partnership with the Alliance for Pharmacy Compounding


Please note that this is the on-demand version of the webinar for APC Pharmacy/Facility Members.
The live webinar was recorded on August 18th, 2022.

 

Overview

Compounders working with hazardous drugs (HD) face the daily challenge of surface contamination, as HD poses a threat of unintended exposure unless proper removal from work surfaces takes place. Despite practice and quality standards set out by USP Chapter <800>, confusion remains among the compounding community with HD removal, particularly decontamination.

This activity aims to clarify the purpose of decontamination of non-sterile and sterile preparations by exploring the differences between deactivation, decontamination, cleaning, and disinfection, as well as discussing appropriate agents for the decontamination of HD on surfaces. Under a practice setting, the program will also explore the importance of verifying processes and agents for decontaminating, while discussing procedures for validating effective HD decontamination.

Further recognizing the risks of HD exposure and the significance of decontamination can facilitate staff safety and policy compliance, thereby reducing residual surface contamination and hence risk of potentially life-threatening exposure.

Intended audience

    • Pharmacists & Pharmacy Technicians

    Learning Objectives

    Pharmacists

    1. Review the differences between deactivation, decontamination, cleaning, and disinfection.
    2. Discuss agents that are appropriate for the decontamination of hazardous drugs on surfaces.
    3. Explain the importance of verifying the effectiveness of your process and agents for decontaminating hazardous drugs.
    4. Describe options for verifying effective hazardous drug decontamination.

    Pharmacy Technicians

    1. Define decontamination in the context of hazardous drugs removal.
    2. List agents suitable for the decontamination of hazardous drugs on surfaces.
    3. Recognize the significance of validating the effectiveness of your procedure and the agents used for decontaminating hazardous drugs.
    4. Identify ways to facilitate the verification of effective hazardous drug decontamination.

    Hardware/software requirements

    Web browser

    Google Chrome (most recent 2 versions)

    Mozilla Firefox (most recent 2 versions)

    Internet Explorer v11

    Apple Safari (most recent 2 versions)

    Microsoft Edge (most recent 2 versions)

    Internet connection

    Computer: 1 Mbps or better (broadband recommended)

    Mobile device: 3G or better (WiFi recommended)

    Software

    No additional software needed

    Hardware

    		2GB of RAM (minimum), 4GB or more of RAM (recommended)

     

    COPYRIGHT

    This webinar is Copyright © Alliance for Pharmacy Compounding 2022.

    Course summary
    Available credit: 
    • 1.00 Contact Hours
    Price:
    $0.00
    Abby Roth

    Abby Roth, founder of Pure Microbiology, has over 17 years of experience in supporting the testing and consulting needs of the pharmaceutical, medical device, and compounding industries. Her background in pharmaceutical microbiology includes extensive knowledge of environmental monitoring. Abby served as a USP Compounding EC member during the 2015-2020 cycle.

    Abby has been invited to speak for state Boards of Pharmacy and for organizations, such as the National Home Infusion Association (NHIA) and the American Society of Health-System Pharmacists (ASHP), on topics related to viable sampling, sterilization, sterile compounding, and hazardous drugs.

    The accreditation period for this webinar has expired.

    CANCELLATION AND REFUND POLICY

    There are no refunds, returns or transfers upon payment of the credit reporting fee.

    Price

    Price:
    $0.00
    Please login to Enroll or Add to Waitlist
    Course expires: 
    12/31/2031